EUROPE OPIOID DRUGS MARKET 2019-2028

Lifesciences | Pharmaceuticals

EUROPE OPIOID DRUGS MARKET 2019-2028

Market By Product, Application, And Geography | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the Europe opioid drugs market depicts that it will grow at a CAGR of 2.53% in terms of revenue during the forecast period 2019-2028.



Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this report include:

           The UK

           Germany

           Spain

           Italy

           France

           Russia

           Rest of Europe

In the last two decades, the number of opioid drugs being prescribed has surged significantly in the UK. The government has therefore taken note of this issue. Patients in the country share a bond of trust with their family doctors, believing them to know the best. Efforts to educate patients on the ill-effects of opioid addiction may thus prove extremely beneficial.

Furthermore, Cancer Research UK estimates that the rate of incidence of all types of cancers is will grow by 2% in the country in the period from 2016 to 2035. The rate of incidence in the UK is estimated to be higher than two-thirds of the entire European region, with 742 cases per 100,000 people by 2035. Opioids are known for their use in treating cancer patients and relieving their pain. The growth in the number of people being affected by the disease is, therefore, likely to enhance the adoption of these drugs. This will benefit the market for opioid drugs in the United Kingdom.

Spain has witnessed a huge increase in the availability of opioids in the country, over the past few years. However, it must be noted that people are not overdosing on their opioid prescriptions. Nonetheless, some doctors have still warned that the country cannot be complacent when it comes to this issue. For instance, there has been a spike in the consumption of rapid-release fentanyl, which is said to be 50 to 100 times more potent than morphine. This is a worrying development, which has prompted Spain’s health ministry to revamp its prescription guidelines and convene a group of professionals to discuss the matter. These efforts to promote the responsible adoption of opioid drugs is favoring the Spanish market growth.

Allergan PLC is a manufacturer of specialty pharmaceuticals. With its headquarters in Dublin, Ireland, it is a global leader in the pharmaceutical industry, which develops, manufactures, commercializes and distributes generic, branded, and OTC products. The company was acquired by AbbVie in early 2020. Kadian (morphine) is an opioid medication offered by the company. The company also has good cash flow and financial backing.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE OPIOID DRUGS MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1. TECHNOLOGICAL ADVANCEMENTS TO FIGHT AGAINST OPIOID DRUG CRISIS

2.2.2. DIFFERENT SOURCES OF PROCURING OPIOIDS

2.3. PORTER’S FIVE FORCE ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. MARKET DRIVERS

2.6.1. GROWTH IN MEDICAL CASES & RISING PREVALENCE OF CANCER

2.6.2. INCREASE IN THE USE OF ABUSE-DETERRENT FORMULATIONS TO RESTRICT THE RISE OF OPIOID DEPENDENCE

2.6.3. DEMAND FOR PALLIATIVE THERAPY

2.7. MARKET RESTRAINTS

2.7.1. GOVERNMENT RULES AND REGULATIONS

2.7.2. INCREASED NUMBER OF LAWSUITS AGAINST THE MANUFACTURERS OF OPIOD DRUGS

2.7.3. USAGE OF OPIOIDS FOR NON-MEDICAL PURPOSES

2.8. MARKET OPPORTUNITIES

2.8.1. RISING COMMERCIAL SUCCESS AND MARKET SHARE OF OPIOID DRUGS

2.8.2. GROWTH OF INVESTMENTS IN RESEARCH OF PHARMACEUTICAL USES OF OPIOIDS

2.9. MARKET CHALLENGES

2.9.1. OPIOID EPIDEMIC SPREADING

2.9.2. RISING DEATH RATE DUE TO OPIOID OVERDOSE

2.10. COVID-19 IMPACT ON THE OPIOID DRUGS MARKET

3.    EUROPE OPIOID DRUG MARKET OUTLOOK - BY PRODUCT

3.1. BUPRENORPHINE

3.2. FENTANYL

3.3. HYDROCODONE

3.4. MORPHINE

3.5. OXYCODONE

3.6. TRAMADOL

3.7. OTHER PRODUCTS

4.    EUROPE OPIOID DRUGS MARKET OUTLOOK - BY APPLICATION

4.1. PAIN RELIEF

4.1.1. CANCER PAIN

4.1.2. POSTOPERATIVE PAIN MANAGEMENT

4.1.3. LOWER BACK PAIN

4.1.4. ORTHOPEDIC

4.1.5. NEUROPATHIC

4.1.6. FIBROMYALGIA

4.2. ANESTHESIA

4.3. COUGH SUPPRESSION

4.4. DIARRHEA SUPPRESSION

4.5. DE-ADDICTION

5.    EUROPE OPIOID DRUGS MARKET – REGIONAL OUTLOOK

5.1. UNITED KINGDOM

5.2. GERMANY

5.3. FRANCE

5.4. SPAIN

5.5. ITALY

5.6. RUSSIA

5.7. REST OF EUROPE

6.    COMPETITIVE LANDSCAPE

6.1. ACURA PHARMACEUTICALS

6.2. BIODELIVERY SCIENCES INTERNATIONAL INC

6.3. CIPHER PHARMACEUTICALS INC

6.4. ALLERGAN (ACQUIRED BY ABBVIE)

6.5. COLLEGIUM PHARMACEUTICAL INC

6.6. DAIICHI SANKYO

6.7. HIKMA PHARMACEUTICALS PLC

6.8. INDIVIOR INC

6.9. JANSSEN PHARMACEUTICALS INC

6.10. JOHNSON JOHNSON

6.11. LANNETT CO INC

6.12. LUPIN LTD

6.13. MYLAN NV

6.14. PFIZER INC

6.15. PURDUE PHARMA LP

6.16. SANOFI-AVENTIS SA

6.17. SUN PHARMACEUTICAL INDUSTRIES LTD

6.18. TEVA PHARMACEUTICAL INDUSTRIES LTD

7.    METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of table

TABLE 1: EUROPE OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: EUROPE OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)

TABLE 4: EUROPE OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)

TABLE 5: EUROPE OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)

TABLE 6: EUROPE OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: EUROPE OPIOID DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)

FIGURE 4: EUROPE OPIOID DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)

FIGURE 5: EUROPE OPIOID DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)

FIGURE 6: EUROPE OPIOID DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)

FIGURE 7: EUROPE OPIOID DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)

FIGURE 8: EUROPE OPIOID DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)

FIGURE 9: EUROPE OPIOID DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)

FIGURE 10: EUROPE OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)

FIGURE 11: EUROPE OPIOID DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)

FIGURE 12: EUROPE OPIOID DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)

FIGURE 13: EUROPE OPIOID DRUGS MARKET, BY LOWER BACK PAIN, 2019-2028 (IN $ MILLION)

FIGURE 14: EUROPE OPIOID DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)

FIGURE 15: EUROPE OPIOID DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)

FIGURE 16: EUROPE OPIOID DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)

FIGURE 17: EUROPE OPIOID DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)

FIGURE 18: EUROPE OPIOID DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)

FIGURE 19: EUROPE OPIOID DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)

FIGURE 20: EUROPE OPIOID DRUGS MARKET, BY DE-ADDICTION, 2019-2028 (IN $ MILLION)

FIGURE 21: EUROPE OPIOID DRUGS MARKET; REGIONAL OUTLOOK 2019 & 2028 (IN %)

FIGURE 22: UNITED KINGDOM OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: GERMANY OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: FRANCE OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: SPAIN OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 26: ITALY OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 27: RUSSIA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 28: REST OF EUROPE OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;